Published in PLoS One on September 07, 2010
Inflammation in the pathogenesis of microvascular complications in diabetes. Front Endocrinol (Lausanne) (2012) 1.24
Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin system. Cancer Res (2012) 0.93
Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice. J Neuroinflammation (2013) 0.91
Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats. PLoS One (2012) 0.87
The kallikrein-kinin system and oxidative stress. Curr Opin Nephrol Hypertens (2012) 0.83
Activation of kinin B1 receptor evokes hyperthermia through a vagal sensory mechanism in the rat. J Neuroinflammation (2012) 0.79
Activation of TRPV1 by capsaicin induces functional kinin B(1) receptor in rat spinal cord microglia. J Neuroinflammation (2012) 0.78
Acute and subchronic exposure to air particulate matter induces expression of angiotensin and bradykinin-related genes in the lungs and heart: Angiotensin-II type-I receptor as a molecular target of particulate matter exposure. Part Fibre Toxicol (2015) 0.78
A primary role for kinin B1 receptor in inflammation, organ damage, and lethal thrombosis in a rat model of septic shock in diabetes. Eur J Inflamm (2015) 0.76
Kinin B1 and B2 receptor deficiency protects against obesity induced by a high-fat diet and improves glucose tolerance in mice. Diabetes Metab Syndr Obes (2015) 0.76
Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure. Indian J Pharmacol (2015) 0.75
Effects of Alpha-Lipoic Acid on Oxidative Stress and Kinin Receptor Expression in Obese Zucker Diabetic Fatty Rats. J Diabetes Metab (2015) 0.75
Angiotensin-converting enzyme inhibitors reduce oxidative stress intensity in hyperglicemic conditions in rats independently from bradykinin receptor inhibitors. Croat Med J (2016) 0.75
Interplay between the kinin B1 receptor and inducible nitric oxide synthase in insulin resistance. Br J Pharmacol (2016) 0.75
Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers. Oxid Med Cell Longev (2015) 0.75
Kinin B1 Receptor Promotes Neurogenic Hypertension Through Activation of Centrally Mediated Mechanisms. Hypertension (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol (2006) 7.84
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest (1996) 6.38
Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res (1998) 3.30
NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care (2008) 3.07
International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev (2005) 2.98
Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest (1995) 2.94
Fructose-induced insulin resistance and hypertension in rats. Hypertension (1987) 2.43
Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J Appl Physiol (1985) (2008) 2.40
Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci U S A (2000) 2.11
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res (2009) 1.82
Vascular Angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats. Hypertens Res (2007) 1.67
Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci U S A (2000) 1.63
Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev (2006) 1.58
Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol (2007) 1.57
Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats. J Hypertens (2002) 1.55
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci U S A (2004) 1.45
Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes. J Hypertens (2005) 1.44
Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors. J Clin Invest (2006) 1.38
Bradykinin receptors and their antagonists. Eur J Pharmacol (1998) 1.36
Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension. Circ Res (2001) 1.32
Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta. J Pharmacol Exp Ther (2005) 1.28
Tolerance of rats to hyperoxia. Lung antioxidant enzyme gene expression. J Clin Invest (1993) 1.27
Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc Natl Acad Sci U S A (2010) 1.26
Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int (1999) 1.25
Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin. Blood (2006) 1.24
High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes (1996) 1.23
Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol (2004) 1.17
Detrimental implication of B1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice. Int Immunopharmacol (2002) 1.15
Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation. Hypertension (2008) 1.14
Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction. Hypertension (2005) 1.12
Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension (2002) 1.11
Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biol Chem (2010) 1.10
Calibration of 125I-polymer standards with 125I-brain paste standards for use in quantitative receptor autoradiography. J Neurosci Methods (1989) 1.06
The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int (2009) 1.04
Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus. Eur J Pharmacol (2004) 1.02
Effect of alpha-lipoic acid on lipid profile in rats fed a high-fructose diet. Exp Diabesity Res (2004) 0.99
Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes (1998) 0.99
Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain. Trends Pharmacol Sci (2006) 0.97
Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes (2008) 0.96
Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors. Hypertension (2008) 0.95
Prevention of fructose-induced hypertension by dietary vitamins. Clin Biochem (2004) 0.93
Role of oxidative stress in multiparity-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol (2008) 0.93
NADPH oxidases are responsible for the failure of nitric oxide to inhibit migration of smooth muscle cells exposed to high glucose. Free Radic Biol Med (2009) 0.93
Kinin receptors: functional aspects. Int Immunopharmacol (2002) 0.92
Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance. Neuropeptides (2007) 0.91
Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model. Am J Physiol Renal Physiol (2008) 0.90
Deletion of bradykinin B1 receptor reduces renal fibrosis. Int Immunopharmacol (2008) 0.88
Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins. J Pharmacol Exp Ther (1993) 0.88
Neuropathic pain-like behavior after brachial plexus avulsion in mice: the relevance of kinin B1 and B2 receptors. J Neurosci (2008) 0.88
Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocin-induced diabetic rats treated with curcumin. J Cardiovasc Pharmacol (2005) 0.87
Identification of an axotomy-induced glycosylated protein, AIGP1, possibly involved in cell death triggered by endoplasmic reticulum-Golgi stress. J Neurosci (2002) 0.87
Aldehyde induced hypertension in rats: prevention by N-acetyl cysteine. Artery (1998) 0.86
The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy. Biol Chem (2006) 0.86
Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice. Clin Exp Pharmacol Physiol (2008) 0.86
Blockade of sensory abnormalities and kinin B(1) receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance. Eur J Pharmacol (2008) 0.85
The kinin B1 receptor antagonist SSR240612 reverses tactile and cold allodynia in an experimental rat model of insulin resistance. Br J Pharmacol (2007) 0.85
Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats. Br J Pharmacol (2002) 0.85
Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2001) 0.83
Angiotensin II chronic infusion induces B1 receptor expression in aorta of rats. Hypertension (2007) 0.83
Contribution of the central dopaminergic system in the anti-hypertensive effect of kinin B1 receptor antagonists in two rat models of hypertension. Neuropeptides (2010) 0.82
Kinins in cardiac inflammation and regeneration: insights from ischemic and diabetic cardiomyopathy. Neuropeptides (2009) 0.81
High-fructose diet decreases catalase mRNA levels in rat tissues. J Endocrinol Invest (2001) 0.81
Increases of spinal kinin receptor binding sites in two rat models of insulin resistance. Peptides (2005) 0.81
High glucose increases B1-kinin receptor expression and signaling in endothelial cells. Biochem Biophys Res Commun (2006) 0.80
Hemodynamic and renal involvement of B1 and B2 kinin receptors during the acute phase of endotoxin shock in mice. Int Immunopharmacol (2007) 0.80
Cardioprotection of bradykinin at reperfusion involves transactivation of the epidermal growth factor receptor via matrix metalloproteinase-8. Acta Physiol (Oxf) (2009) 0.80
DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. Am J Hypertens (1993) 0.79
Role of oxidative stress in high glucose-induced decreased expression of Gialpha proteins and adenylyl cyclase signaling in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2008) 0.79
Modulation of kinin B1 receptor expression by endogenous angiotensin II in hypertensive rats. Regul Pept (2006) 0.79
Effects of alpha-lipoic acid on kinin B1 and B2 receptor binding sites in the spinal cord of chronically angiotensin-treated rats. Peptides (2005) 0.78
Cross talk between kinin and angiotensin II receptors in mouse abdominal aorta. Biol Chem (2009) 0.78
Comparative ability of certain sugars and honey to enhance saline polydipsia and salt hypertension. Proc Soc Exp Biol Med (1966) 0.76
Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid (2003) 4.48
Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes. J Neuroimmunol (2007) 1.47
Nuclear retention of MBP mRNAs in the quaking viable mice. Neuron (2002) 1.41
Structural and functional aspects of thyroid peroxidase. Arch Biochem Biophys (2005) 1.14
Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy. J Neuroinflammation (2010) 0.98
Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes (2008) 0.96
Modulation of retinal blood flow by kinin B₁ receptor in Streptozotocin-diabetic rats. Exp Eye Res (2011) 0.92
Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice. J Neuroinflammation (2013) 0.91
In Vivo Anti-Diabetic Activity of the Ethanolic Crude Extract of Sorbus decora C.K.Schneid. (Rosacea): A Medicinal Plant Used by Canadian James Bay Cree Nations to Treat Symptoms Related to Diabetes. Evid Based Complement Alternat Med (2011) 0.91
Up-regulation of kinin B1 receptor in the lung of streptozotocin-diabetic rat: autoradiographic and functional evidence. Br J Pharmacol (2003) 0.90
Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can J Physiol Pharmacol (2002) 0.89
Quantitative and regional measurement of retinal blood flow in rats using N-isopropyl-p-[14C]-iodoamphetamine ([14C]-IMP). Exp Eye Res (2009) 0.89
Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats. PLoS One (2012) 0.87
Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat. Br J Pharmacol (2003) 0.86
Expression and distribution of kinin B1 receptor in the rat brain and alterations induced by diabetes in the model of streptozotocin. Synapse (2005) 0.86
Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells. Int J Cancer (2002) 0.86
Kinin B1 receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: receptors and mechanisms. Am J Physiol Heart Circ Physiol (2010) 0.85
Mechanism of cigarette smoke-induced kinin B(1) receptor expression in rat airways. Peptides (2010) 0.85
Blockade of sensory abnormalities and kinin B(1) receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance. Eur J Pharmacol (2008) 0.85
Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats. Br J Pharmacol (2002) 0.85
Cellular localization of kinin B1 receptor in the spinal cord of streptozotocin-diabetic rats with a fluorescent [Nalpha-Bodipy]-des-Arg9-bradykinin. J Neuroinflammation (2009) 0.85
Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor. Am J Physiol Renal Physiol (2012) 0.84
The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation. Br J Pharmacol (2005) 0.84
Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2. Eur J Pharmacol (2006) 0.84
Autoradiographic detection of kinin receptors in the human medulla of control, hypertensive, and diabetic donors. Can J Physiol Pharmacol (2002) 0.83
Expression of kinin B1 receptors in the spinal cord of streptozotocin-diabetic rat. Neuroreport (2004) 0.82
Comparative effects of N-acetyl-L-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats. Can J Physiol Pharmacol (2008) 0.82
Production of an agonist-like monoclonal antibody to the human A2A receptor of adenosine for clinical use. Mol Immunol (2008) 0.82
Increases of spinal kinin receptor binding sites in two rat models of insulin resistance. Peptides (2005) 0.81
Autoradiographic analysis of rat brain kinin B1 and B2 receptors: normal distribution and alterations induced by epilepsy. J Comp Neurol (2003) 0.81
Disposable versus reusable biopsy forceps in GI endoscopy: a cost-minimization analysis. Gastrointest Endosc (2003) 0.81
[Bradykinin receptors: towards new pathophysiological roles]. Med Sci (Paris) (2003) 0.81
Effect of chronic inhibition of nitric oxide on hypertension, insulin resistance, and cardiovascular remodeling in glucose-fed rats. J Cardiovasc Pharmacol (2009) 0.81
An ex vivo approach to the differential parenchymal responses induced by cigarette whole smoke and its vapor phase. Toxicology (2012) 0.81
Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study. Br J Pharmacol (2003) 0.81
Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats. Br J Pharmacol (2004) 0.81
Cigarette smoke-induced kinin B1 receptor promotes NADPH oxidase activity in cultured human alveolar epithelial cells. Peptides (2011) 0.80
Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists. Neuropeptides (2003) 0.80
Emerging role of microglial kinin B1 receptor in diabetic pain neuropathy. Exp Neurol (2011) 0.80
Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure. Br J Pharmacol (2006) 0.80
Total serum tryptase levels are higher in young infants. Pediatr Allergy Immunol (2011) 0.80
Central anti-hypertensive effect of tachykinin NK3 receptor antagonists in rat. Eur J Pharmacol (2004) 0.80
Dairy fat blends high in α-linolenic acid are superior to n-3 fatty-acid-enriched palm oil blends for increasing DHA levels in the brains of young rats. J Nutr Biochem (2012) 0.80
Suppression of vascular inflammation by kinin B1 receptor antagonism in a rat model of insulin resistance. J Cardiovasc Pharmacol (2012) 0.80
[Functional duality of kinin receptors in pathophysiology]. Med Sci (Paris) (2003) 0.79
Activation of kinin B1 receptor evokes hyperthermia through a vagal sensory mechanism in the rat. J Neuroinflammation (2012) 0.79
Androgen-dependent expression of FcgammaRIIB2 by thyrocytes from patients with autoimmune Graves' disease: a possible molecular clue for sex dependence of autoimmune disease. FASEB J (2002) 0.79
Autoradiographic analysis of mouse brain kinin B1 and B2 receptors after closed head trauma and ability of Anatibant mesylate to cross the blood-brain barrier. J Neurotrauma (2006) 0.79
Kinin B2 receptor is not involved in enalapril-induced apoptosis and regression of hypertrophy in spontaneously hypertensive rat aorta: possible role of B1 receptor. Br J Pharmacol (2004) 0.79
Antigenicity and immunogenicity of the C-terminal peptide of human thyroglobulin. Peptides (2004) 0.79
Detection of thyroid peroxidase mRNA and protein in orbital tissue. Eur J Endocrinol (2006) 0.79
A pentylenetetrazole-induced generalized seizure in early life enhances the efficacy of muscarinic receptor coupling to G-protein in hippocampus and neocortex of adult rat. Eur J Neurosci (2005) 0.79
Impact of α-lipoic acid on liver peroxisome proliferator-activated receptor-α, vascular remodeling, and oxidative stress in insulin-resistant rats. Can J Physiol Pharmacol (2011) 0.79
Analysis of a conformational B cell epitope of human thyroid peroxidase: identification of a tyrosine residue at a strategic location for immunodominance. Int Immunol (2002) 0.79
Effects of angiotensin-1 converting enzyme inhibition on oxidative stress and bradykinin receptor expression during doxorubicin-induced cardiomyopathy in rats. J Cardiovasc Pharmacol (2008) 0.78
Complement activation by direct C4 binding to thyroperoxidase in Hashimoto's thyroiditis. Endocrinology (2003) 0.78
Human thyroperoxidase folds in one complex B-cell immunodominant region. Biochem Biophys Res Commun (2002) 0.78
Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord. Am J Physiol Heart Circ Physiol (2003) 0.78
Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation. Am J Physiol Renal Physiol (2002) 0.78
Assessment of retinal and choroidal blood flow changes using laser Doppler flowmetry in rats. Curr Eye Res (2012) 0.78
Effects of alpha-lipoic acid on kinin B1 and B2 receptor binding sites in the spinal cord of chronically angiotensin-treated rats. Peptides (2005) 0.78
Activation of TRPV1 by capsaicin induces functional kinin B(1) receptor in rat spinal cord microglia. J Neuroinflammation (2012) 0.78
Evidence that the complement control protein-epidermal growth factor-like domain of thyroid peroxidase lies on the fringe of the immunodominant region recognized by autoantibodies. Thyroid (2002) 0.78
Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding protein. Cancer Res (2003) 0.78
The kallikrein-kinin system in diabetic retinopathy. Prog Drug Res (2014) 0.77
Autoradiographic distribution and alterations of kinin B(2) receptors in the brain and spinal cord of streptozotocin-diabetic rats. Synapse (2005) 0.76
Evidence for a GABA(B) receptor component in the spinal action of Substance P (SP) on arterial blood pressure in the awake rat. Br J Pharmacol (2002) 0.76
Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats. Br J Pharmacol (2010) 0.75
Feasibility of and interest in combined endoscopic ultrasonography and biliary drainage in unexplained acute biliopancreatic disorders. Dig Dis Sci (2002) 0.75
Managing irritable bowel syndrome: The impact of micro-physiotherapy. J Complement Integr Med (2017) 0.75
An in vitro model based on cell monolayers grown on the underside of large- pore filters in bicameral chambers for studying thyrocyte-lymphocyte interactions. Am J Physiol Cell Physiol (2004) 0.75
The role of the paratrigeminal nucleus in the pressor response to sciatic nerve stimulation in the rat. Auton Neurosci (2008) 0.75
Cellular localisation of the kinin B1R in the pancreas of streptozotocin-treated rat and the anti-diabetic effect of the antagonist SSR240612. Biol Chem (2016) 0.75
Quantitation of mRNA levels by RT-PCR in cells purified by FACS. Application to peripheral cannabinoid receptors in leukocyte subsets. Methods Mol Biol (2002) 0.75
Urinary iodine analysis: an alternative method for digestion of urine samples. Clin Chem (2004) 0.75
[New perspectives for bradykinin in nephroprotection]. Med Sci (Paris) (2007) 0.75